Nonischaemic priapism associated with selective serotonin-3 receptor antagonist
| Autor: | Ö. Atahan, G. Kilciler, Mete Kilciler, Mustafa Kadihasanoglu |
|---|---|
| Přispěvatelé: | Atahan, O. |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Serotonin
medicine.drug_class Urology Priapism 030232 urology & nephrology urologic and male genital diseases 030226 pharmacology & pharmacy Ondansetron 03 medical and health sciences 0302 clinical medicine Endocrinology medicine Sexual stimulation Nonischaemic business.industry Antagonist General Medicine medicine.disease Receptor antagonist Pathophysiology medicine.anatomical_structure Anesthesia business Penis medicine.drug |
| Popis: | Kadihasanoglu, Mustafa/0000-0001-5109-5319 WOS:000408624600018 PubMed: 27709642 Priapism is a rare but severe urological emergency of erection of penis in the absence of physical and psychological sexual stimulation. Priapism is often idiopathic and is commonly associated with medications and underlying medical or traumatic causes. In this report, we present a case of a 70-year-old White Caucasian man who developed priapism after the administration of ondansetron, which is a selective serotonin type-3 (5-HT3) receptor antagonist. This case is unique, because, to date, there are only two presented cases in literature. The objective of this case report is to highlight the importance of recognising the possibility of priapism with ondansetron because this condition is not commonly seen in clinical practice to be associated with ondansetron and may go unrecognised. Also, potential pathophysiological mechanisms involved in the development of ondansetron-induced priapism are presented. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|